We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Molecular Mechanisms of Retina Pathology and Ways of its Correction
Price data last checked 103 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
This book discusses the pathology of the retina, and reviews current research on the use of cell replacement therapy and short peptides to restore functional activity in retinal neurons. As the book describes, pathologies of the retina, including age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa, present a long-standing challenge in the practice of clinical ophthalmology. Modern treatment for these conditions, which lead to irreversible blindness, includes laser exposure, surgical intervention, and drugs. These treatments aim to reduce the risk of new complications in the eye; pathogenetic therapy of degenerative diseases of the retina is practically absent in current ophthalmic practice. The first section of the book reviews the molecular mechanisms of age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa, and reports on methods of treatment. The second section presents the results of recent experimental studies ofthe effects of short peptides on pluripotent embryonic cells; on proliferative activity in retinal cells and pigment epithelium; on expression of markers of differentiation or retinal neurons and pigment epithelium; and on the course of hereditary retinal pigmentation in Campbell rats. The third section offers results of clinical studies on the effectiveness of short peptides in patients with macular degeneration, and in patients with retinitis pigmentosa. The author concludes that the regular use of peptides in the treatment of degenerative diseases of the retina can slow the progression of the pathological process and preserve the patient’s vision for some 10-15 years. In addition, in 80 percent of patients, it is possible to increase visual function by increasing visual acuity, improving the boundaries of the visual field and the fundus.
Product Specifications
- Format
- paperback
- ASIN
- 3030501620
- Domain
- Amazon UK
- Release Date
- 18 July 2021
- Listed Since
- 20 June 2021
Barcode
No barcode data available
Similar Products You Might Like
94% match
Neuroprotection and Neuroregeneration for Retinal Diseases
Springer
£84.86
20 Apr 2026
94% match
Retinal Degenerative Diseases: Laboratory and Therapeutic Investigations: 664 (Advances in Experimental Medicine and Biology, 664)
Springer
£212.92
13 Jan 2026
94% match
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1185 (Advances in Experimental Medicine and Biology, 1185)
Springer
£77.76
25 Jan 2026
94% match
Cellular Therapies for Retinal Disease: A Strategic Approach
Springer
£107.52
09 Mar 2026
94% match
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1074 (Advances in Experimental Medicine and Biology, 1074)
Springer
£213.33
06 Apr 2026
94% match
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1185 (Advances in Experimental Medicine and Biology, 1185)
£246.03
23 Jan 2026
94% match
Studies on Retinal and Choroidal Disorders (Oxidative Stress in Applied Basic Research and Clinical Practice)
Humana
£141.36
04 Mar 2026
94% match
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1074 (Advances in Experimental Medicine and Biology, 1074)
Springer
£135.64
27 Jan 2026
94% match
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology, 801)
Springer
£179.00
27 Jan 2026
94% match
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology)
Springer
£210.79
27 Jan 2026
93% match
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 854 (Advances in Experimental Medicine and Biology, 854)
Springer
£156.36
06 Mar 2026
93% match
Pediatric Retina
Springer
£164.18
07 Jan 2026
93% match
Retinal Degenerations: Mechanisms and Experimental Therapy: 533 (Advances in Experimental Medicine and Biology, 533)
Springer
£150.15
23 Jan 2026
93% match
Inherited Retinal Disease
£103.81
13 Jan 2026
93% match
Inherited Retinal Disease
£98.20
11 Jan 2026
93% match
Macular Dystrophies
Springer
£88.73
07 Feb 2026
93% match
Vitreo-retinal Surgery (Essentials in Ophthalmology)
Springer
£82.29
09 Dec 2025
93% match
Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases: 35 (Topics in Medicinal Chemistry, 35)
Springer
£144.00
23 Jan 2026
93% match
Studies on Retinal and Choroidal Disorders: Oxidative Stress in Applied Basic Research and Clinical Practice
Humana
£78.00
28 Mar 2026
93% match
Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases: 35 (Topics in Medicinal Chemistry, 35)
£201.56
25 Jan 2026
93% match
Diabetic Retinopathy: Current Pharmacologic Treatment and Emerging Strategies
Adis
£73.85
08 Mar 2026
93% match
Springer Age-related Macular Degeneration - Medical Textbook
Springer
£109.82
04 Apr 2026
93% match
Mouse Retinal Phenotyping: Methods and Protocols: 1753 (Methods in Molecular Biology, 1753)
Humana
£117.60
31 Jan 2026
93% match
Recent Advances In Retinal Degeneration: 613 (Advances in Experimental Medicine and Biology, 613)
Springer
£149.64
10 Mar 2026